Hepatitis B vaccine not associated with childhood multiple sclerosis

Several studies have evaluated a possible association between the hepatitis B vaccine and the autoimmune neurological disease multiple sclerosis (MS) in adults, according to background information in the article. Most have found no significant increase in the risk of MS in the short or long term, although one identified a potentially increased risk within three years of vaccination.

“Some of these epidemiologic studies have been criticized for methodological limitations,” including how vaccination status was confirmed, the authors write. “This controversy created public misgivings about hepatitis B vaccination. Hepatitis B vaccination in children remained low in several countries despite vaccination campaigns supporting early vaccination against hepatitis B in children as a means of inducing strong and long-lasting immunity and despite high levels of hepatitis B–related morbidity and mortality worldwide.”

Yann Mikaeloff, M.D., Ph.D., of Hôpital Bicêtre, Le Kremlin Bicêtre, France, and colleagues studied 143 children who developed MS before age 16, with a first episode of the disease occurring between 1994 and 2003. Each patient was matched to an average of eight control participants from the general French population who were the same age and sex and lived in the same location but did not have MS. Telephone interviews and questionnaires were used to collect vaccination records and information about family history of MS or other autoimmune diseases.

In the three years before the first episode of MS, approximately 32 percent of both the 143 patients and the 1,122 controls were vaccinated against hepatitis B. “Vaccination against hepatitis B within the three-year study period was not associated with an increased rate of a first episode of MS,” the authors write. “The rate was also not increased for hepatitis B vaccination within six months of the index date or at any time since birth or as a function of the number of injections or the brand of hepatitis B vaccine.”

“Vaccination against hepatitis B does not seem to increase the risk of a first episode of MS in childhood,” they conclude.

Source: JAMA and Archives Journals

Sweat may pass on hepatitis B in contact sports
Sweat may be another way to pass on hepatitis B infection during contact sports, suggests research published ahead of print in the British Journal of Sports Medicine.
Tool creates personalized catch-up immunization schedules for missed childhood vaccinations
A new downloadable software tool will help pediatricians, parents and other health care professionals determine how to adjust complex childhood immunization schedules when one or more vaccine doses aren’t received at the proper time.
Hepatitis B virus triggers cell 'suicide' in patients with chronic infection
Scientists from UCL (University College London) have identified a key difference between people who can fight the Hepatitis B virus (HBV) off successfully and those who fail to do so – that a group of cells important in controlling the disease are triggered to ‘commit suicide’ in patients who are chronically infected. This discovery provides an important new focus for developing therapies or vaccines that boost the body’s ability to manage this infection.
Parents follow pediatrician advice on administering MMR vaccinations
News stories about an allegedly harmful link between the mumps, measles and rubella vaccine and the onset of autism had little effect on whether U.S. parents immunized their children, according to a review of immunization records and news stories. Parents’ decisions were more likely influenced by recommendations from their child’s pediatrician, the researchers said.
Medical Scientists Develop Rice-Based Vaccination To Fight Pandemic Disease
Scientists in Japan have developed a rice-based vaccination for cholera. The methodology can be applied to other types of pandemic diseases created by bio-terrorism. The advantage of utilizing this type of vaccination include the ability to store at room temperatures for 1.5 years. In addition, the vaccine is oral and may be widely dispensed in the event of wide-spread disease.
Japan facing vaccination lawsuits
The Japanese government is bracing for a flood of damage suits from hundreds of people who contracted hepatitis B through mandatory childhood vaccinations.
New upper limit defined for normal ALT in adolescent males
A new cohort study of adolescent offenders in Australia has identified an upper limit for ALT that is more sensitive for the diagnosis of liver disease. The findings could facilitate targeted interventions for the youths in this group, who are at high risk for HCV infection and obesity-related liver disease. The study is in the December issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.
Combination vaccines okay for infants, study shows
A University of Rochester study brings relief to new parents who, while navigating a jam-packed childhood vaccine schedule, can expect to soothe their newborn through as many as 15 “pokes” by his or her six-month checkup.

Hepatitis B vaccine not associated with childhood multiple sclerosis

Related stories:

News discussion: